Index AR1 - Anticancer Research

More documents

Recommendations

Info

ANTICANCER RESEARCH 28: Index (2008) Down-regulated Expression of RhoA in Human Conventional Renal Cell Carcinoma. Y.-S. PU, C.-W. WANG, G.-Y. LIU, Y.-Z. KUO, C.-Y. HUANG, W.-Y. KANG, C.-T. SHUN, C.-C. LIN, W.-J. WU, T.-C. HOUR (Taipei; Kaohsiung; Taichung, Taiwan, ROC)...................................................................................................................... Long-term Postoperative Adjuvant Chemotherapy of UFT/LV Improves Survival in a Primary Tumor Amputation, Pulmonary Metastasis Model. S. SADAHIRO, T. SUZUKI, Y. MAEDA, A. TANAKA, H. MAKUUCHI, A. KAMIJ, C. MURAYAMA (Tokai, Japan) ........................................................................................................ EMMPRIN Modulates Migration and Deposition of TN-C in Oral Squamous Carcinoma. D. DANG, A. ATAKILIT, D.M. RAMOS (San Francisco, CA, USA)...................................................................................... SPMSP: A Solid-phase PCR with Colorimetric Read-out for Quantitative Methylation Analysis. S. SIEVERS, C. FRITZSCH, C. KUHNEN, O. MÜLLER (Dortmund; Bochum, Germany)........................................................ Aberrant Gene Promoter Methylation in Sputum from Individuals Exposed to Smoky Coal Emissions. Y. LIU, Q. LAN, M. SHEN, J. JIN, J. MUMFORD, D. REN, P. KEOHAVONG (Pittsburgh, PA; Bethesda, MD; Triangle Park, NC, USA) ...................................................................................................................................... Inhibition of Growth and Induction of Differentiation of Colon Cancer Cells by Peach and Plum Phenolic Compounds. M.A. LEA, C. IBEH, C. desBORDES, M. VIZZOTTO, L. CISNEROS-ZEVALLOS, D.H. BYRNE, W.R. OKIE, M.P. MOYER (Newark, NJ, New York, NY; College Station, TX; Byron, GA; San Antonio, TX, USA; Pelotas, Brazil)....................................................................................................................... Human Papillomavirus Frequency in Oral and Oropharyngeal Cancer in Greece. M. ROMANITAN, A. NÄSMAN, T. RAMQVIST, H. DAHLSTRAND, L. POLYKRETIS, P. VOGIATZIS, P. VAMVAKAS, G. TASOPOULOS, C. VALAVANIS, P. ARAPANTONI-DADIOTI, K. BANIS, T. DALIANIS (Stockholm, Sweden; Piraeus, Greece) ......................................................................................................................... The Synthesis and Activity of Lipoprotein Lipase in the Subcutaneous Adipose Tissue of Patients with Musculoskeletal Sarcomas. K. SAKAYAMA, T. KIDANI, N. TANJI, H. YAMAMOTO, H. MASUNO (Toon; Iyo-gun, Ehime, Japan) ..................................................................................................................................... Oxaliplatin in Treatment of the Cisplatin-resistant MKN45 Cell Line of Gastric Cancer. K. TOZAWA, T. OSHIMA, T. KOBAYASHI, N. YAMAMOTO, C. HAYASHI, T. MATSUMOTO, H. MIWA (Nishinomiya, Hyogo; Sapporo, Hokkaido, Japan) .............................................................................................................. Regulation of Inflammation- and Angiogenesis-related Gene Expression in Breast Cancer Cells and Co-cultured Macrophages. G.T. BURNETT, D.C. WEATHERSBY, T.E. TAYLOR, T.A. BREMNER (Washington DC; Houston, TX, USA) ......................................................................................................................... Lipopolysaccharide Induces Aberrant Hypermethylation of Hic-1 in Mouse Embryonic Fibroblasts Lacking p53 Gene. M. TATEMICHI, H. HATA, H. TAZAWA, T. NAKADATE (Tokyo; Okayama, Japan)............. Investigation of MMP-2 and -9 in a Highly Invasive A431 Tumor Cell Sub-line Selected from a Boyden Chamber Assay. W.-T. KAO, C.-Y. LIN, L.-T. LEE, P.-P.H. LEE, C.-C. HUNG, Y.-S. LIN, S. CHEN, F.-C. KE, J.-J. HWANG, M.-T. LEE (Taipei; Chia-Yi, ∆aiwan, ROC) ................................................................. HOXB2, an Adverse Prognostic Indicator for Stage I Lung Adenocarcinomas, Promotes Invasion by Transcriptional Regulation of Metastasis-related Genes in HOP-62 Non-small Cell Lung Cancer Cells. K. INAMURA, Y. TOGASHI, H. NINOMIYA, T. SHIMOJI, T. NODA, Y. ISHIKAWA (Tokyo, Japan) .... The Anti-aromatase Effect of Progesterone and of its Natural Metabolites 20·- and 5·-Dihydroprogesterone in the MCF-7aro Breast Cancer Cell Line. J.R. PASQUALINI, G. CHETRITE (Paris, France) .......................... Evidence of a Tumour Suppressive Function of E2F1 Gene in Human Breast Cancer. D. WORKU, F. JOUHRA, G.W. JIANG, N. PATANI, R.F. NEWBOLD, K. MOKBEL (Uxbridge, Middlesex; London; Cardiff, UK) .............. 2039 2045 2049 2055 2061 2067 2077 2081 2087 2093 2101 2109 2121 2129 2135 4203
ANTICANCER RESEARCH 28: Index (2008) Restoration of FGF Receptor Type 2 Enhances Radiosensitivity of Hormone-refractory Human Prostate Carcinoma PC-3 Cells. A. MATSUBARA, J. TEISHIMA, S. MIRKHAT, H. YASUMOTO, H. MOCHIZUKI, M. SEKI, K. MUTAGUCHI, W.L. MCKEEHAN, T. USUI (Hiroshima; Hatsukaichi, Japan; Houston, TX, USA) ............................................................................................................................................... Efficacy of the Third-generation Bisphosphonate Risedronate Alone and in Combination with Anticancer Drugs Against Osteosarcoma Cell Lines. T. MURAYAMA, Y. KAWASOE, Y. YAMASHITA, Y. UENO, S. MINAMI, M. YOKOUCHI, S. KOMIYA (Kagoshima, Japan) ........................................................................ The Wilms’ Tumor Suppressor WT1 Inhibits Malignant Progression of Neoplastigenic Mammary Epithelial Cells. L. WANG, Z.-Y. WANG (Omaha, NE, USA) ............................................................................................... Aberrant Methylation of p16, DLEC1, BLU and E-Cadherin Gene Promoters in Nasopharyngeal Carcinoma Biopsies from Tunisian Patients. W. AYADI, H. KARRAY-HAKIM, A. KHABIR, L. FEKI, S. CHARFI, T. BOUDAWARA, A. GHORBEL, J. DAOUD, M. FRIKHA, P. BUSSON, A. HAMMAMI (Sfax, Tunisie; Villejuif, France).................................................................................................................................... Follow-up of HPV DNA Copy Number in Cidofovir Therapy of Recurrent Respiratory Papillomatosis. T. MAJOR, I. SZIKLAI, J. CZEGLÉDY, T. GÁLL, L. GERGELY, K. SZARKA (Debrecen, Hungary) ......... Resistance of Colorectal Cancer Cells to 5-FUdR and 5-FU Caused by Mycoplasma Infection. L. JETTÉ, S. BISSOON-HAQQANI, B. LE FRANÇOIS, J.A. MAROUN, H.C. BIRNBOIM (Ottawa, ON, Canada)............. Abrogation of Estrogen Receptor Signaling Augments Cytotoxicity of Anticancer Drugs on CaSki Cervical Cancer Cells. M.Y. HEO, S.A. SALAMA, N. KHATOON, A. AL-HENDY, W.W. AU (Chuncheon, Korea; Galveston, TX, USA)...................................................................................................................................................... Comparison of 111 In-DOTA-NOC and 111 In-DOTA-TATE Distribution in the Target and Dose-limiting Tissues: Conflicting Results In Vitro and In Vivo. J. CIHLO, L. MELICHAROVÁ, M. PETRIK, A. LAZNICKOVA, M. LAZNICEK (Hradec Kralove, Czech Republic)............................................................... Tumor-specific Cytotoxicity and Type of Cell Death Induced by Peplomycin in Oral Squamous Cell Carcinoma Cell Lines. Y. LIU, H. SAKAGAMI, O. AMANO, H. KIKUCHI, Y. NAKAMURA, M. ISHIHARA, Y. KANDA, S. KUNII, W. ZHANG, G. YU (Beijing, China; Sakado, Saitama, Japan)........................................ Down-regulation of Deoxycytidine Kinase Enhances Acquired Resistance to Gemcitabine in Pancreatic Cancer. S. OHHASHI, K. OHUCHIDA, K. MIZUMOTO, H. FUJITA, T. EGAMI, J. YU, H. TOMA, S. SADATOMI, E. NAGAI, M. TANAKA (Fukuoka, Japan)............................................................................... The Growth-promoting Action of Individual Women’s Sera on Mammary Carcinoma Cells. D. AUER, M. HUBALEK, M. FLEISCHER, J. ROESSLER, G. DAXENBICHLER (Innsbruck, Austria) .................... Measurement of Serum and Tissue Des-Á-carboxyprothrombin in Resectable Hepatocellular Carcinoma. C.-H. XIANG, W. ZHANG, Y. INAGAKI, K.-M. ZHANG, Y. NAKANO, N. KOKUDO, Y. SUGAWARA, J.-H. DONG, M. NAKATA, W. TANG (Tokyo; Hiratsuka, Japan; Beijing; Shanghai, China).............................. Arp2/3 Overexpression Contributed to Pathogenesis, Growth and Invasion of Gastric Carcinoma. H.-C. ZHENG, Y.-S. ZHENG, X.-H. LI, H. TAKAHASHI, T. HARA, S. MASUDA, X.-H. YANG, Y.-F. GUAN, Y. TAKANO (Shenyang, China; Toyama; Takaoka, Japan) .......................................................... Prevalence of HPV Types in a Cohort of Greeks with Clinical Indication of Infection. C. YAPIJAKIS, M. ADAMOPOULOU, G. ANTONOPOULOS, N. KOUFALIOTIS, E. VAIRAKTARIS (Athens, Greece) ......... Effect of Bortezomib and Cetuximab in EGF-stimulated HNSCC. J. WAGENBLAST, M. BAGHI, C. ARNOLDNER, S. BISDAS, W. GSTÖTTNER, H. ACKERMANN, A. MAY, R. KNECHT, M. HAMBEK (Frankfurt am Main, Germany) .................................................................................................................................... 4204 2141 2147 2155 2161 2169 2175 2181 2189 2197 2205 2213 2219 2225 2233 2239
Page 1 and 2: ANTICANCER RESEARCH International J
Page 3 and 4: Editorial Board ANTICANCER RESEARCH
Page 5 and 6: ANTICANCER RESEARCH 28: Index (2008
Page 7 and 8: Department of Health, Executive Yua
Page 9 and 10: National R&D Program for Cancer Con
Page 11 and 12: Number 1A Experimental Studies ANTI
Page 15 and 16: * ANTICANCER RESEARCH 28: Index (20
Page 17 and 18: Amelanotic Metastasis of Melanoma M
Page 23 and 24: * ANTICANCER RESEARCH 28: Index (20
Page 25 and 26: Detection of Oncogenic DNA Viruses
Page 27 and 28: Gross Thymic Extract, Thymax, Induc
Page 31: * Number 4A Special Issue on Prosta
Page 37 and 38: Adjuvant Treatment for Elderly Pati
Page 45 and 46: * * ANTICANCER RESEARCH 28: Index (
Page 47 and 48: Number 6B Clinical Studies ANTICANC
Page 49 and 50: Abstracts of the 14th International
Page 51 and 52: Aggrecan, versican, decorin, Wester
Page 53 and 54: Apoptosis, inotodiol, lanostane tri
Page 55 and 56: Bone metastases, bisphosphonates, z
Page 57 and 58: Capecitabine, colorectal cancer, ir
Page 59 and 60: Chemoresistance, cancer of unknown
Page 61 and 62: Colorectal adenoma, Cox-2 polymorph
Page 63 and 64: Cytotoxicity, ferrocene, β-diketon
Page 65 and 66: Electrochemiluminescence immunoassa
Page 67 and 68: Ferrocene, β-diketone, cytotoxicit
Page 69 and 70: Genistein, soy extract, MDA-MB-231
Page 71 and 72: Histone deacetylase inhibitor, vita
Page 73 and 74: Infusion, 5-fluorouracil, arterial,
Page 75 and 76: Liver metastasis, pioglitazone, col
Page 77 and 78: Melphalan, hyperthermia, apoptosis,
Page 79 and 80: Mucin, adenocarcinoma, metastatic b
Page 81 and 82: Oesophageal cancer, carboplatin, el
Page 83 and 84:
P53, syndecan-1, tenascin-C, TATI,
Page 85 and 86:
Plumbagin, apoptosis, pro-apoptotic
Page 87 and 88:
ProGRP, small cell lung cancer, NSE
Page 89 and 90:
RA-resistance, leukemia cells, reti
Page 91 and 92:
S-1, cisplatin, advanced pancreatic
Page 93 and 94:
Sonic hedgehog, breast cancer, estr
Page 95 and 96:
Thrombosis, gynecological cancer, c
Page 97 and 98:
Type of cell death, β-cyclodextrin
Page 99 and 100:
Authors Index (Figures refer to pag
Page 101 and 102:
Cho S-H, 2649 Choi MS, 3777 Chorti
Page 103 and 104:
Giuliani L, 1405 Goda T, 2343 Goess
Page 105 and 106:
Katano M, 731, 2401 Katayama K, 847
Page 107 and 108:
Mahajan A, 741 Maiti A, 3705 Majka
Page 109 and 110:
Onogawa T, 2669 Onouchi S, 145 Onoz
Page 111 and 112:
Scotti M, 1951 Sculli CM, 3055 Seco
Page 113 and 114:
Usami M, 3913 Ushijima R, 601 Usui
Page 115 and 116:
Errata ANTICANCER RESEARCH 28: Inde
Page 117 and 118:
Medicherla et al: TGF-‚ Inhibitor
Page 119 and 120:
Volume 28 (2008), No 2A, page 1072:
Page 121:
Publication Data: ANTICANCER RESEAR
show all

Index AR1 - Anticancer Research

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?